Cizzle Biotechnology (CIZ) Share Price, News & Analysis

ETF Overview

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.

Key Stats

• Today's Range: 1.71 to 1.80
• 50-Day Range: 1.40 to 2.40
• 52-Week Range: 1.30 to 2.69
• Volume: 322,518 shs
• Average Volume: 1.28 million shs
• Market Capitalization: £6.99 million
• Assets Under Management: £48.98 million
• Dividend Yield: 63.70%
• Net Expense Ratio: 0.46%
• Aggregate Rating: N/A

CIZ ETF - Frequently Asked Questions

How have CIZ shares performed this year?

Cizzle Biotechnology's stock was trading at GBX 1.59 at the beginning of 2025. Since then, CIZ stock has increased by 11.6% and is now trading at GBX 1.77.
View the best growth stocks for 2025 here.

How were Cizzle Biotechnology's earnings last quarter?

Cizzle Biotechnology Holdings Plc (LON:CIZ) announced its quarterly earnings data on Wednesday, April, 30th. The company reported ($0.60) earnings per share for the quarter.

How do I buy shares of Cizzle Biotechnology?

Shares of CIZ stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Cizzle Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cizzle Biotechnology investors own include Progressive (PGR), Qorvo (QRVO), TAL Education Group (TAL), Teekay Tankers (TNK), Waters (WAT), Preferred Apartment Communities (APTS) and Baidu (BIDU).

Fund Details

• Issuer: Victory Capital Management
• Fund Name: VictoryShares Developed Enhanced Volatility Wtd ETF
• Tax Classification: Regulated Investment Company
• Stock Exchange: LON
• Current Symbol: LON:CIZ
• Inception Date: 9/30/2014
• Fund Manager: Mannik Dhillon, Stephen Hammers
• Web: www.cizzlebiotechnology.com
• Phone: 44-20-3934-6630

Fund Focus

• Asset Class: Equity
• Benchmark: Nasdaq Victory?International 500 Long/Cash Volatility Weighted Index
• Category: Size and Style
• Focus: Large Cap
• Development Level: Developed Markets
• Region: Global Ex-U.S.
• Number of Holdings: 505

Fund Statistics

• Assets Under Management: $48.98 million
• Average Daily Volume: $9.24 thousand
• Discount/Premium: 0.17%

Administrator, Advisor and Custodian

• Administrator: Victory Capital Management Inc.
• Advisor: Victory Capital Management Inc.
• Custodian: Citibank, N.A.
• Distributor: Foreside Fund Services, LLC
• Transfer Agent: Citibank, N.A.
• Trustee: N/A
• Lead Market Maker: RBC Capital Markets

Options

• Optionable: N/A
• Short Interest: 15,600 shs

Miscellaneous

• Outstanding Shares: 394,139,773
• Beta: 0.38
• Creation Unit: 50,000
• Creation Fee: $4,500.00